The application of high-resolution mass spectrometry to type and subtype strains of the influenza virus within recent recommended vaccine formulations is described. Proteolytic digests of whole virus or separated hemagglutinin antigen generate conserved signature peptides of unique mass that can be used to characterise each component virus in a rapid and direct manner by the detection of their ions alone. The approach is demonstrated for two type A strains and one type B strain of human influenza viruses present in recommended seasonal vaccines in the northern and southern hemispheres from 2007 through 2010.
WoodJ.M.WilliamsM.S., History of Inactivated Influenza Vaccines.Blackwell Science, Oxford, UK (1998).
2.
WoodJ.M., “Developing vaccines against pandemic influenza.”Philos. Trans. Roy. Soc. Lond. Series B Biol. Sci.356, 1953 (2001). doi: 10.1098/rstb.2001.0981
3.
CarratF.FlahaultA., “Influenza vaccine: The challenge of antigenic drift”, Vaccine25, 6852 (2007). doi: 10.1016/j.vaccine.2007.07.027
4.
MainesT.R.LuX.H.ErbS.M.EdwardsL.GuarnerJ.GreerP.W.NguyenD.C.SzretterK.J.ChenL-M.ThawatsuphaP.ChittaganpitchM.WaicharoenS.NguyenD.T.NguyenT.NguyenH.H.T.KimJ.-H.HoangL.T.KangC.PhuongL.S.LimW.ZakiS.DonisR.O.CoxN.J.KatzJ.M.TumpeyT.M., “Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals”, J. Virol.79, 11788 (2005). doi: 10.1128/JVI.79.18.11788-11800.2005
5.
GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.SessionsW.M.XuX.SkepnerE.DeydeV.Okomo-AdhiamboM.GubarevaL.BarnesJ.SmithC.B.EmeryS.L.HillmanM.J.RivaillerP.SmagalaJ.de GraafM.BurkeD.F.FouchierR.A.PappasC.Alpuche-ArandaC.M.López-GatellH.OliveraH.LópezI.MyersC.A.FaixD.BlairP.J.YuC.KeeneK.M.DotsonP.D.JrBoxrudD.SambolA.R.AbidS.H.St GeorgeK.BannermanT.MooreA.L.StringerD.J.BlevinsP.Demmler-HarrisonG.J.GinsbergM.KrinerP.WatermanS.SmoleS.GuevaraH.F.BelongiaE.A.ClarkP.A.BeatriceS.T.DonisR.KatzJ.FinelliL.BridgesC.B.ShawM.JerniganD.B.UyekiT.M.SmithD.J.KlimovA.I.CoxN.J., “Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans”, Science325, 197 (2009). doi: 10.1126/science.1176225
6.
StöhrK., The WHO global influenza program and its animal influenza network, Avian Dis.47, 934 (2003). doi: 10.1637/0005-2086-47.s3.934
7.
KingN.O'ConnellJ. (Eds) “RT-PCR Protocols” in Methods in Molecular Biology.Humana Press, New Jersey, USA (2002).
8.
WrightK.E.WilsonG.A.NovosadD.DimockC.TanD.WeberJ.M., “Typing and subtyping of influenza viruses in clinical samples by PCR”, J. Clin. Microbiol.33, 1180 (1995).
9.
KiselarJ.G.DownardK.M., “Antigenic surveillance of the influenza virus with mass spectrometry”, Biochemistry38, 14185 (1999). doi: 10.1021/bi991609j
10.
MorrisseyB.DownardK.M., “A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry”, Proteomics6, 2034 (2006). doi: 10.1002/pmic.200500642
11.
MorrisseyB.StreamerM.DownardK.M., “Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry”, J. Virol. Methods145, 106 (2007). doi: 10.1016/j.jviromet.2007.05.015
12.
SchwahnA.B.WongJ.W.H.DownardK.M., “Subtyping of the influenza virus by high resolution mass spectrometry”, Anal. Chem.81, 3500 (2009). doi: 10.1021/ac900026f
13.
SchwahnA.B.WongJ.W.H.DownardK.M., “Signature peptides of influenza nucleoprotein for the typing and subtyping of the virus by high resolution mass spectrometry”, Analyst134, 2253(2009). doi: 10.1039/b912234f
14.
SchwahnA.B.DownardK.M., “Antigenicity of a type a influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays”J. Immunoass. Immunochem.30, 245 (2009). doi: 10.1080/15321810903084350
15.
KiselarJ.G.DownardK.M., “Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody–peptide complexes”, Anal. Chem.71, 1792 (1999). doi: 10.1021/ac9811120
16.
DownardK.M., “Characterization of the conformations of antigenic peptides of protein lactate dehydrogenase (LDH-C4) by electrospray ionization mass spectrometry”, Rapid Commun. Mass Spectrom.11, 1853 (1997). doi: 10.1002/(SICI)1097-0231(199711)11:17<1853::AID-RCM75>3.0.CO;2-5
17.
MorrisseyB.DownardK.M., “Kinetics of antigen–antibody interactions employing a MALDI mass spectrometry immunoassay”Anal. Chem.80, 7720 (2008). doi: 10.1021/ac801069q
18.
GerdilC., “The annual production cycle for influenza vaccine”, Vaccine21, 1776 (2003). doi: 10.1016/S0264-410X(03)00071-9
19.
SavilleM.MarshG.HoffenbachA., “Improving seasonal and pandemic influenza vaccines”, Influenza and Other Respiratory Viruses2, 229 (2008). doi: 10.1111/j.1750-2659.2008.00060.x
RussellC.A.JonesT.C.BarrI.G.CoxN.J.GartenR.J.GregoryV.GustI.D.HampsonA.W.HayA.J.HurtA.C.de JongJ.C.KielsoA.KlimovA.I.KageyamaT.KomadinaN.LapedesA.S.LinY.P.MosterinA.ObuchiM.OdagiriT.OsterhausA.D.RimmelzwaanG.F.ShawM.W.SkepnerE.StöhrK.TashiroM.FouchierR.A.SmithD.J., “Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses”, Vaccine26, D31 (2008). doi: 10.1016/j.vaccine.2008.07.078
ToshP.K.BoyceT.G.PolandG.A., “Flu myths: Dispelling the myths associated with live attenuated influenza vaccine”, Mayo Clin. Proc.83, 77 (2008). doi: 10.4065/83.1.77
24.
MyersM.G.TaurasoN.M., “Identification and quantitation of the components of polyvalent inactivated influenza virus vaccines by immunodiffusion”, Appl. Microbiol.23, 946 (1972).
25.
WoodJ.M.SchildG.C.NewmanR.W.SeagroattV., “An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines”, J. Biol. Stand.5, 237 (1977). doi: 10.1016/S0092-1157(77)80008-5
26.
KapteynJ.C.SaidiM.D.DijkstraR.KarsC.TjonJ.C.WeverlingG.J.de VochtM.L.KompierR.van MontfortB.A.GuichouxJ.Y.GoudsmitJ.LagerwerfF.M., “Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: A novel RP-HPLC method”, Vaccine24, 3137 (2006). doi: 10.1016/j.vaccine.2006.01.046
27.
BaoY.BolotovP.DernovoyD.KiryutinB.ZaslavskyL.TatusovaT.OstellJ.LipmanD., “The influenza virus resource at the National Center for Biotechnology Information”, J. Virol.82, 596 (2008). doi: 10.1128/JVI.02005-07
28.
LarkinM.A.BlackshieldsG.BrownN.P.ChennaR.McGettiganP.A.McWilliamH.ValentinF.WallaceI.M.WilmA.LopezR.ThompsonJ.D.GibsonT.J.HigginsD.G., “Clustal W and Clustal X version 2.0”, Bioinformatics23, 2947 (2007). doi: 10.1093/bioinformatics/btm404
29.
McCullersJ.A.SaitoT.IversonA.R., “Multiple genotypes of Influenza B Virus circulated between 1979 and 2003”, J. Virol.78, 12817 (2004). doi: 10.1128/JVI.78.23.12817-12828.2004
